e-ISSN: Pending
Negative / Null Result ReportOpen accessMedicine· cited by 9

NANO-LM: An updated scorecard for the clinical assessment of patients with leptomeningeal metastases

Émilie Le Rhun; Lakshmi Nayak; Mary Jane Lim-Fat; Roberta Rudà; Elena Pentsova; Peter Forsyth; Barbara O’Brien; Matthias Preusser · 2024 · Neuro-Oncology

WASTE classifies this as Negative / Null Result Report · AI classification, approximate

The study found no significant effect — useful as a negative control or null benchmark for your own design.

Abstract

BACKGROUND: There are no validated tools for the clinical neurological assessment of patients with leptomeningeal metastases (LM). However, clinical examination during the course of the disease guides medical management and is part of response assessment in clinical trials. Because neuroimaging may not always be obtained owing to rapid clinical deterioration, clinical neurological assessment of LM is essential, and standardization is important to minimize rater disagreement. METHODS: The Response Assessment in Neuro-oncology-LM group launched a 2-step process, aiming at improving and standardi

Abstract by Émilie Le Rhun; Lakshmi Nayak; Mary Jane Lim-Fat; Roberta Rudà; Elena Pentsova; Peter Forsyth; Barbara O’Brien; Matthias Preusser, Neuro-Oncology (2024) — licensed CC BY 4.0.

About to run something similar?

Run an AI Precheck on your own design to catch failure modes like this one before you spend the time. Your first desk check is free.

WASTE indexes this work — it does not host or republish it. Failure-type classification is automated and approximate.

Metadata source: OpenAlex · DOI 10.1093/neuonc/noae171